CMS
Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test
The company's tumor genotyping test will now be reimbursed for eligible Medicare patients under Palmetto GBA's local coverage determination for this class of assays.
Pillar Biosciences Receives CMS Coverage for Pan-Cancer CDx Assay
The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.
Minnesota Bill Could Expedite Medicaid Coverage for Newborns Based on Disease Screening Results
Premium
Under the proposed bill, SF 1175, newborns who test positive in an initial screen would be presumed eligible for disability benefits through Medicaid.
US Department of Health and Human Services to Lay Off 10K Workers in Restructuring
The move is part of the Trump Administration's Department of Government Efficiency, or DOGE, Workforce Optimization Initiative.
Guardant Health's Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic Status
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.
Aug 8, 2024
Local Coverage Determinations Roundup: Veracyte
May 1, 2024